Permeasis Therapeutics
PrivateLast Round
Seed
Oct 10, 2024
Company Overview
Permeasis Therapeutics is a biotechnology company developing intracellular biologics enabled by its proprietary Membrane Translocation Domain (MTD) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Permeasis Therapeutics Comparables
Compare Permeasis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyGenica | 85% | |
| Feldan Therapeutics | 84% | |
| Xelcis Bio, Inc. | 82% |
Permeasis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 10, 2024 |
Permeasis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cure Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2024
Seed round led by Cure Ventures.
Permeasis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Permeasis Therapeutics's valuation, stock price, and market status.
Is Permeasis Therapeutics a public or private company?
Permeasis Therapeutics is a private company.
What is the current stock price of Permeasis Therapeutics?
Permeasis Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Permeasis Therapeutics worth (valuation)?
Valuation information for Permeasis Therapeutics is not publicly available.
Can I buy Permeasis Therapeutics stock?
Permeasis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Permeasis Therapeutics's last funding round?
Permeasis Therapeutics's most recent funding round was Seed on October 10, 2024.
Who are the main investors in Permeasis Therapeutics?
Key investors in Permeasis Therapeutics include Cure Ventures.
Will Permeasis Therapeutics IPO soon?
No public IPO plans have been announced for Permeasis Therapeutics.
How can I track Permeasis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Permeasis Therapeutics's secondary market activity and sign up for updates.